Table of Contents Chapter 1 Overview of Guaifenesin 1.1 Definition of Guaifenesin in This Report 1.2 Commercial Types of Guaifenesin 1.2.1 98%-99% 1.2.2 >99% 1.3 Downstream Application of Guaifenesin 1.3.1 Pharmaceuticals 1.3.2 Personal Care Products 1.3.3 Others 1.4 Development History of Guaifenesin 1.5 Market Status and Trend of Guaifenesin 2013-2023 1.5.1 Global Guaifenesin Market Status and Trend 2013-2023 1.5.2 Regional Guaifenesin Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Guaifenesin 2013-2017 2.2 Sales Market of Guaifenesin by Regions 2.2.1 Sales Volume of Guaifenesin by Regions 2.2.2 Sales Value of Guaifenesin by Regions 2.3 Production Market of Guaifenesin by Regions 2.4 Global Market Forecast of Guaifenesin 2018-2023 2.4.1 Global Market Forecast of Guaifenesin 2018-2023 2.4.2 Market Forecast of Guaifenesin by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Guaifenesin by Types 3.2 Sales Value of Guaifenesin by Types 3.3 Market Forecast of Guaifenesin by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Guaifenesin by Downstream Industry 4.2 Global Market Forecast of Guaifenesin by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Guaifenesin Market Status by Countries 5.1.1 North America Guaifenesin Sales by Countries (2013-2017) 5.1.2 North America Guaifenesin Revenue by Countries (2013-2017) 5.1.3 United States Guaifenesin Market Status (2013-2017) 5.1.4 Canada Guaifenesin Market Status (2013-2017) 5.1.5 Mexico Guaifenesin Market Status (2013-2017) 5.2 North America Guaifenesin Market Status by Manufacturers 5.3 North America Guaifenesin Market Status by Type (2013-2017) 5.3.1 North America Guaifenesin Sales by Type (2013-2017) 5.3.2 North America Guaifenesin Revenue by Type (2013-2017) 5.4 North America Guaifenesin Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Guaifenesin Market Status by Countries 6.1.1 Europe Guaifenesin Sales by Countries (2013-2017) 6.1.2 Europe Guaifenesin Revenue by Countries (2013-2017) 6.1.3 Germany Guaifenesin Market Status (2013-2017) 6.1.4 UK Guaifenesin Market Status (2013-2017) 6.1.5 France Guaifenesin Market Status (2013-2017) 6.1.6 Italy Guaifenesin Market Status (2013-2017) 6.1.7 Russia Guaifenesin Market Status (2013-2017) 6.1.8 Spain Guaifenesin Market Status (2013-2017) 6.1.9 Benelux Guaifenesin Market Status (2013-2017) 6.2 Europe Guaifenesin Market Status by Manufacturers 6.3 Europe Guaifenesin Market Status by Type (2013-2017) 6.3.1 Europe Guaifenesin Sales by Type (2013-2017) 6.3.2 Europe Guaifenesin Revenue by Type (2013-2017) 6.4 Europe Guaifenesin Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Guaifenesin Market Status by Countries 7.1.1 Asia Pacific Guaifenesin Sales by Countries (2013-2017) 7.1.2 Asia Pacific Guaifenesin Revenue by Countries (2013-2017) 7.1.3 China Guaifenesin Market Status (2013-2017) 7.1.4 Japan Guaifenesin Market Status (2013-2017) 7.1.5 India Guaifenesin Market Status (2013-2017) 7.1.6 Southeast Asia Guaifenesin Market Status (2013-2017) 7.1.7 Australia Guaifenesin Market Status (2013-2017) 7.2 Asia Pacific Guaifenesin Market Status by Manufacturers 7.3 Asia Pacific Guaifenesin Market Status by Type (2013-2017) 7.3.1 Asia Pacific Guaifenesin Sales by Type (2013-2017) 7.3.2 Asia Pacific Guaifenesin Revenue by Type (2013-2017) 7.4 Asia Pacific Guaifenesin Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Guaifenesin Market Status by Countries 8.1.1 Latin America Guaifenesin Sales by Countries (2013-2017) 8.1.2 Latin America Guaifenesin Revenue by Countries (2013-2017) 8.1.3 Brazil Guaifenesin Market Status (2013-2017) 8.1.4 Argentina Guaifenesin Market Status (2013-2017) 8.1.5 Colombia Guaifenesin Market Status (2013-2017) 8.2 Latin America Guaifenesin Market Status by Manufacturers 8.3 Latin America Guaifenesin Market Status by Type (2013-2017) 8.3.1 Latin America Guaifenesin Sales by Type (2013-2017) 8.3.2 Latin America Guaifenesin Revenue by Type (2013-2017) 8.4 Latin America Guaifenesin Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Guaifenesin Market Status by Countries 9.1.1 Middle East and Africa Guaifenesin Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Guaifenesin Revenue by Countries (2013-2017) 9.1.3 Middle East Guaifenesin Market Status (2013-2017) 9.1.4 Africa Guaifenesin Market Status (2013-2017) 9.2 Middle East and Africa Guaifenesin Market Status by Manufacturers 9.3 Middle East and Africa Guaifenesin Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Guaifenesin Sales by Type (2013-2017) 9.3.2 Middle East and Africa Guaifenesin Revenue by Type (2013-2017) 9.4 Middle East and Africa Guaifenesin Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Guaifenesin 10.1 Global Economy Situation and Trend Overview 10.2 Guaifenesin Downstream Industry Situation and Trend Overview Chapter 11 Guaifenesin Market Competition Status by Major Manufacturers 11.1 Production Volume of Guaifenesin by Major Manufacturers 11.2 Production Value of Guaifenesin by Major Manufacturers 11.3 Basic Information of Guaifenesin by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Guaifenesin Major Manufacturer 11.3.2 Employees and Revenue Level of Guaifenesin Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Guaifenesin Major Manufacturers Introduction and Market Data 12.1 Granules 12.1.1 Company profile 12.1.2 Representative Guaifenesin Product 12.1.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Granules 12.2 Synthokem Labs 12.2.1 Company profile 12.2.2 Representative Guaifenesin Product 12.2.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Synthokem Labs 12.3 Haizhou Pharma 12.3.1 Company profile 12.3.2 Representative Guaifenesin Product 12.3.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Haizhou Pharma 12.4 Yuan Cheng Group 12.4.1 Company profile 12.4.2 Representative Guaifenesin Product 12.4.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Yuan Cheng Group 12.5 Stellar Chemical 12.5.1 Company profile 12.5.2 Representative Guaifenesin Product 12.5.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Stellar Chemical 12.6 Biesterfeld 12.6.1 Company profile 12.6.2 Representative Guaifenesin Product 12.6.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Biesterfeld 12.7 Seven Star Pharma 12.7.1 Company profile 12.7.2 Representative Guaifenesin Product 12.7.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Seven Star Pharma 12.8 Camlin Fine Science 12.8.1 Company profile 12.8.2 Representative Guaifenesin Product 12.8.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Camlin Fine Science 12.9 Gennex Lab 12.9.1 Company profile 12.9.2 Representative Guaifenesin Product 12.9.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Gennex Lab 12.10 Iwaki Seiyaku 12.10.1 Company profile 12.10.2 Representative Guaifenesin Product 12.10.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Iwaki Seiyaku 12.11 Pan Drugs 12.11.1 Company profile 12.11.2 Representative Guaifenesin Product 12.11.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Pan Drugs 12.12 Delta Synthetic 12.12.1 Company profile 12.12.2 Representative Guaifenesin Product 12.12.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Delta Synthetic 12.13 Smart Pharm 12.13.1 Company profile 12.13.2 Representative Guaifenesin Product 12.13.3 Guaifenesin Sales, Revenue, Price and Gross Margin of Smart Pharm Chapter 13 Upstream and Downstream Market Analysis of Guaifenesin 13.1 Industry Chain of Guaifenesin 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Guaifenesin 14.1 Cost Structure Analysis of Guaifenesin 14.2 Raw Materials Cost Analysis of Guaifenesin 14.3 Labor Cost Analysis of Guaifenesin 14.4 Manufacturing Expenses Analysis of Guaifenesin Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of 98%-99% Table Advantage and Disadvantage of >99% Table Sales Volume of Guaifenesin by Regions 2013-2017 Table Sales Value of Guaifenesin by Regions 2013-2017 Table Production Volume of Guaifenesin by Regions 2013-2017 Table Global Sales Volume of Guaifenesin by Regions 2018-2023 Table Global Sales Value of Guaifenesin by Regions 2018-2023 Table Global Production Volume of Guaifenesin by Regions 2018-2023 Table Sales Volume of Guaifenesin by Types 2013-2017 Table Sales Value of Guaifenesin by Types 2013-2017 Table Sales Volume Forecast of Guaifenesin by Types 2018-2023 Table Sales Value Forecast of Guaifenesin by Types 2018-2023 Table Sales Volume of Guaifenesin by Downstream Industry 2013-2017 Table Sales Volume Forecast of Guaifenesin by Downstream Industry 2018-2023 Table North America Guaifenesin Sales by Countries (2013-2017) Table North America Guaifenesin Sales Share by Countries (2013-2017) Table North America Guaifenesin Revenue by Countries (2013-2017) Table North America Guaifenesin Revenue Market Share by Countries (2013-2017) Table North America Guaifenesin Sales by Type (2013-2017) Table North America Guaifenesin Sales Share by Type (2013-2017) Table North America Guaifenesin Revenue by Type (2013-2017) Table North America Guaifenesin Revenue Share by Type (2013-2017) Table North America Guaifenesin Sales by Downstream Industry (2013-2017) Table North America Guaifenesin Sales Share by Downstream Industry (2013-2017) Table Europe Guaifenesin Sales by Countries (2013-2017) Table Europe Guaifenesin Sales Share by Countries (2013-2017) Table Europe Guaifenesin Revenue by Countries (2013-2017) Table Europe Guaifenesin Revenue Market Share by Countries (2013-2017) Table Europe Guaifenesin Sales by Type (2013-2017) Table Europe Guaifenesin Sales Share by Type (2013-2017) Table Europe Guaifenesin Revenue by Type (2013-2017) Table Europe Guaifenesin Revenue Share by Type (2013-2017) Table Europe Guaifenesin Sales by Downstream Industry (2013-2017) Table Europe Guaifenesin Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Guaifenesin Sales by Countries (2013-2017) Table Asia Pacific Guaifenesin Sales Share by Countries (2013-2017) Table Asia Pacific Guaifenesin Revenue by Countries (2013-2017) Table Asia Pacific Guaifenesin Revenue Market Share by Countries (2013-2017) Table Asia Pacific Guaifenesin Sales by Type (2013-2017) Table Asia Pacific Guaifenesin Sales Share by Type (2013-2017) Table Asia Pacific Guaifenesin Revenue by Type (2013-2017) Table Asia Pacific Guaifenesin Revenue Share by Type (2013-2017) Table Asia Pacific Guaifenesin Sales by Downstream Industry (2013-2017) Table Asia Pacific Guaifenesin Sales Share by Downstream Industry (2013-2017) Table Latin America Guaifenesin Sales by Countries (2013-2017) Table Latin America Guaifenesin Sales Share by Countries (2013-2017) Table Latin America Guaifenesin Revenue by Countries (2013-2017) Table Latin America Guaifenesin Revenue Market Share by Countries (2013-2017) Table Latin America Guaifenesin Sales by Type (2013-2017) Table Latin America Guaifenesin Sales Share by Type (2013-2017) Table Latin America Guaifenesin Revenue by Type (2013-2017) Table Latin America Guaifenesin Revenue Share by Type (2013-2017) Table Latin America Guaifenesin Sales by Downstream Industry (2013-2017) Table Latin America Guaifenesin Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Guaifenesin Sales by Regions (2013-2017) Table Middle East and Africa Guaifenesin Sales Share by Regions (2013-2017) Table Middle East and Africa Guaifenesin Revenue by Regions (2013-2017) Table Middle East and Africa Guaifenesin Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Guaifenesin Sales by Type (2013-2017) Table Middle East and Africa Guaifenesin Sales Share by Type (2013-2017) Table Middle East and Africa Guaifenesin Revenue by Type (2013-2017) Table Middle East and Africa Guaifenesin Revenue Share by Type (2013-2017) Table Middle East and Africa Guaifenesin Sales by Downstream Industry (2013-2017) Table Middle East and Africa Guaifenesin Sales Share by Downstream Industry (2013-2017) Table Production Volume of Guaifenesin by Major Manufacturers 2013-2017 Table Production Value of Guaifenesin by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Guaifenesin Major Manufacturer Table Employees and Revenue Level of Guaifenesin Major Manufacturer Table Representative Guaifenesin Product One of Granules Table Representative Guaifenesin Product Two of Granules Table Guaifenesin Sales, Revenue, Price and Gross Margin of Granules 2013-2017 Table Representative Guaifenesin Product One of Synthokem Labs Table Representative Guaifenesin Product Two of Synthokem Labs Table Guaifenesin Sales, Revenue, Price and Gross Margin of Synthokem Labs 2013-2017 Table Representative Guaifenesin Product One of Haizhou Pharma Table Representative Guaifenesin Product Two of Haizhou Pharma Table Guaifenesin Sales, Revenue, Price and Gross Margin of Haizhou Pharma 2013-2017 Table Representative Guaifenesin Product One of Yuan Cheng Group Table Representative Guaifenesin Product Two of Yuan Cheng Group Table Guaifenesin Sales, Revenue, Price and Gross Margin of Yuan Cheng Group 2013-2017 Table Representative Guaifenesin Product One of Stellar Chemical Table Representative Guaifenesin Product Two of Stellar Chemical Table Guaifenesin Sales, Revenue, Price and Gross Margin of Stellar Chemical 2013-2017 Table Representative Guaifenesin Product One of Biesterfeld Table Representative Guaifenesin Product Two of Biesterfeld Table Guaifenesin Sales, Revenue, Price and Gross Margin of Biesterfeld 2013-2017 Table Representative Guaifenesin Product One of Seven Star Pharma Table Representative Guaifenesin Product Two of Seven Star Pharma Table Guaifenesin Sales, Revenue, Price and Gross Margin of Seven Star Pharma 2013-2017 Table Representative Guaifenesin Product One of Camlin Fine Science Table Representative Guaifenesin Product Two of Camlin Fine Science Table Guaifenesin Sales, Revenue, Price and Gross Margin of Camlin Fine Science 2013-2017 Table Representative Guaifenesin Product One of Gennex Lab Table Representative Guaifenesin Product Two of Gennex Lab Table Guaifenesin Sales, Revenue, Price and Gross Margin of Gennex Lab 2013-2017 Table Representative Guaifenesin Product One of Iwaki Seiyaku Table Representative Guaifenesin Product Two of Iwaki Seiyaku Table Guaifenesin Sales, Revenue, Price and Gross Margin of Iwaki Seiyaku 2013-2017 Table Representative Guaifenesin Product One of Pan Drugs Table Representative Guaifenesin Product Two of Pan Drugs Table Guaifenesin Sales, Revenue, Price and Gross Margin of Pan Drugs 2013-2017 Table Representative Guaifenesin Product One of Delta Synthetic Table Representative Guaifenesin Product Two of Delta Synthetic Table Guaifenesin Sales, Revenue, Price and Gross Margin of Delta Synthetic 2013-2017 Table Representative Guaifenesin Product One of Smart Pharm Table Representative Guaifenesin Product Two of Smart Pharm Table Guaifenesin Sales, Revenue, Price and Gross Margin of Smart Pharm 2013-2017